|
![]() |
INNOVATIVE BIOindustries |
|
|
|
|
|
|
|
---|
![]() |
|
December 2019, 3rd |
FEATURE STORY ● Artificial intelligence approach to create AAV capsids for gene therapies DISRUPTIVE TECHNOLOGIES ● Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier CLINICAL TRIALS - DATA ● Libella gene therapeutics to run a patient paid trial of telomerase gene therapy M&A - AGREEMENTS ● Novartis to acquire The Medicines Company for USD 9.7bn, adding inclisiran -● ● ● INVESTMENTS - FUNDRAISING ● Ferring and Blackstone Life Sciences invest over $570 Million USD in novel gene therapy for bladder cancer patients ● Two Chinese companies invest in Vigeneron, a German firm developing ophthalmological gene therapy programs ● Vertex is planning a major expansion in the Seaport ● Thermo Fisher Scientific unveils $6 Million expansion at viral vector manufacturing facility Miscellaneous ● $50M cell and viral vector manufacturing operation backed by Harvard MISCELLANEOUS ● FDA issues guidance for industry on adaptive designs for clinical trials of drugs and biologics |
---|
![]() |
![]() |
|
|
|
![]() |
![]() |
![]() |
|
|
|
![]() |
CLINICAL TRIALS/DATAS |
|
|
![]() |
|
|
|
|
|
![]() |
![]() |
![]() |
|
|
|
![]() |
![]() |
|
![]() |
![]() |
|
|
![]() |
![]() |
|
|
|
![]() |
|
![]() |
|
|
![]() |
|
|
|
|
|
|
|